This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Denis, F.
Right arrow Articles by Sékaly, R.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denis, F.
Right arrow Articles by Sékaly, R.-P.

 Previous Article  |  Next Article 

Journal of Virology, April 2000, p. 3067-3073, Vol. 74, No. 7
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Alternative Proteolytic Processing of Mouse Mammary Tumor Virus Superantigens

François Denis,1,2,dagger Naglaa H. Shoukry,1,3 Marc Delcourt,1,Dagger Jacques Thibodeau,1,2 Nathalie Labrecque,1,§ Helen McGrath,1 J. Scott Munzer,4 Nabil G. Seidah,4 and Rafick-Pierre Sékaly1,2,3,*

Laboratoire d'Immunologie1 and Laboratoire de Biochimie Neuroendocrinienne,4 Institut de Recherches Cliniques de Montréal, Montréal, Quebec, Canada H2W 1R7; Département de Microbiologie-Immunologie, Université de Montréal, Montréal, Quebec, Canada H3C 3J72; and Department of Microbiology and Immunology, McGill University, Montréal, Quebec, Canada H3A 2B43

Received 20 September 1999/Accepted 2 November 1999

Mouse mammary tumor viruses express a superantigen essential for their life cycle. It has been proposed that viral superantigens (vSags) require processing by prohormone convertases (PCs) for activity. We now observe, using a panel of mutant forms of potential PC cleavage sites and in vitro cleavage assays, that only the CS1 (position 68 to 71) and CS2 (position 169 to 172) sites are utilized by furin and PC5. Other members of the convertase family that are expressed in lymphocytes are not endowed with this activity. Furthermore, mutant forms of two different viral superantigens, vSag7 and vSag9, which completely abrogated in vitro processing by convertases, were efficient in functional presentation to responsive T-cell hybridomas. This effect was observed in both endogenous presentation and paracrine transfer of the vSag. Processing by convertases thus appears not to be essential for vSag function. Finally, we have identified the purified endosomal protease cathepsin L as another protease that is able to cleave convertase mutant vSag in vitro, yielding fragments similar to those detected in vivo, thus suggesting that proteases other than convertases are involved in the activation of vSags.


* Corresponding author. Mailing address: Laboratoire d'Immunologie, Institut de Recherches Cliniques de Montréal (IRCM), 110 Ave. des Pins Ouest, Montréal, Quebec, Canada H2W 1R7. Phone: (514) 987-5550. Fax: (514) 987-5711. E-mail: sekalyr{at}ircm.qc.ca.

dagger Present address: Centre de Recherche en Santé Humaine, INRS-IAF, Laval, Quebec, Canada H7V 1B7.

Dagger Present address: Biométhodes, Génopôle Industries, 91000 Evry, France.

§ Present address: Institut de Genetique et de Biologie Moleculaire et Cellulaire, 67404 Illkirch Cedex, France.


Journal of Virology, April 2000, p. 3067-3073, Vol. 74, No. 7
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Azar, G. A., Sekaly, R.-P., Thibodeau, J. (2005). A Defective Viral Superantigen-Presenting Phenotype in HLA-DR Transfectants Is Corrected by CIITA. J. Immunol. 174: 7548-7557 [Abstract] [Full Text]  
  • Mustafa, F., Bhadra, S., Johnston, D., Lozano, M., Dudley, J. P. (2003). The Type B Leukemogenic Virus Truncated Superantigen Is Dispensable for T-Cell Lymphomagenesis. J. Virol. 77: 3866-3870 [Abstract] [Full Text]